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Background. The eﬀects of smoking, alcohol consumption, obesity, and a sedentary lifestyle on endothelial function (EF) have only
been examined separately. The relative contributions of these behaviours on EF have therefore not been compared. Purpose.T o
compare the relative associations between these four risk factors and brachial artery reactivity in the same sample. Methods. 328
patients referred for single-photon emission computed tomography (SPECT) exercise stress tests completed a nuclear-medicine-
based forearm hyperaemic reactivity test. Self-reported exercise behaviour, smoking habits, and alcohol consumption were
collected and waist circumference was measured. Results. Adjusting for relevant covariates, logistic regression analyses revealed
that waist circumference, abstinence from alcohol, and past smoking signiﬁcantly predicted poor brachial artery reactivity while
physical activity did not. Only waist circumference predicted continuous variations in EF. Conclusions. Central adiposity, alcohol
consumption, and smoking habits but not physical activity are each independent predictors of poor brachial artery reactivity in
patients with or at high risk for cardiovascular disease.
1.Introduction
Poorendothelialfunction(EF)predictsfuturecardiovascular
events [1] and is thought to be inﬂuenced by several
behavioural risk factors for cardiovascular disease (CVD)
including smoking, physical activity, obesity, and alcohol
consumption. Thus, poor EF may mediate some of the risks
for CVD created by these behaviours. For example, current
smokers have been found to have lower EF than those who
have never smoked [2–6]. Furthermore, smoking has been
shown to induce an acute decrease in EF [4, 7]. To our
knowledge, however, there has only been one study that has
examined the relationship between lifetime smoking and EF
[8]. While this study found that pack/years were inversely
related to EF, the generalizability of these results may be
limited given the narrow age range of its participants (20–28
years).
Cross-sectional studies have found that sedentary par-
ticipants display reduced EF compared with athletes [9–11],
thoughinconsistencieshavebeennoted[12,13].Whilesome
interventions to increase physical activity have been found
to have a positive impact on EF [12, 14–24], others have
failed to do so [25–28]. To our knowledge, only two studies
have examined the relationship between EF and physical
activity in moderately active participants; one study found
a signiﬁcant eﬀect of physical activity on EF in children [29],
while the other did not ﬁnd a relationship in adults [30].
While obesity is inﬂuenced by several factors, including
physical activity, caloric consumption has been found to be2 International Journal of Hypertension
the most important predictor of weight loss or gain and
caloric restriction to be the most eﬀective means of inducing
weight loss [31–33]. As such, although “obesity” is not a
behaviour per say, here it will be considered a proxy of long-
term excess caloric consumption. Cross-sectional studies
have observed obese and overweight participants, classiﬁed
according to BMI, have worse EF compared to normal
weight controls [34–37]. Intervention studies using either
gastric bypass surgery [38] or a low-calorie diet [39, 40]
have also reported weight loss to result in improvements
in EF. However, only one study to date has examined the
relationship between obesity and EF in participants with a
wide range of BMIs, ﬁnding that both overweight and obese
individuals have worse EF than normal weight controls [41].
The eﬀect of alcohol consumption on EF is equivocal.
While studies comparing alcoholics to nonalcoholic controls
have reported alcoholics to have signiﬁcantly lower EF [42–
44], the impact of moderate amounts of alcohol on EF
is uncertain. Acute wine consumption has generally been
observed to have a positive impact on EF [45–47] though
one study found no diﬀerence in EF when pairing a glass of
red wine versus a control beverage with a high-fat meal [48].
Furthermore, the equivalent of one drink’s worth of ethanol
has resulted in no acute change in EF [49], while four drinks’
worth of ethanol resulted in a signiﬁcant acute decrease in
EF [50]. There has been only one published report on the
relationship between moderate alcohol consumption and
EF. In this study of 108 men with coronary artery disease,
those who drank 1–3 drinks/day had signiﬁcantly better EF
than abstainers, suggesting an inverted J-shaped relationship
between alcohol consumption and EF [51].
While the eﬀects of smoking, physical activity, obesity,
and alcohol consumption on EF have been examined, some
important gaps in knowledge remain. First, there is a lack
of research examining the relationship between lifetime
smoking and EF. Second, further research is needed to
clarify the nature of the relationship between moderate levels
of physical activity and EF. Third, studies are needed to
clarify the relationship between regular moderate alcohol
consumption and EF. Fourth, since most studies on health
behaviours and EF have been conducted in generally healthy
noncardiac samples, this relationship should be explored in
samples that have or are at risk for cardiovascular disease.
Finally,sincethesevariablesoftencooccur,researchisneeded
to determine their independent eﬀects. The primary goal of
thecurrentstudywastoexaminetherelationshipbetweenall
four health behaviours and brachial artery reactivity, used as
a proxy of EF, in a single sample. This allowed determination
of whether each health behaviour had an impact on EF
independent of the others and allowed evaluation of their
relative impact on EF (Table 1).
2. Methods
2.1. Participants. The study was a substudy of the Mech-
anisms and Outcomes of Silent Myocardial Ischemia
(MOSMI) study, a longitudinal study of risk factors for silent
ischemia and the impact of silent ischemia on cardiovascular
Table 1: Summary table.
What is known about the topic What this study adds
(i) Poor endothelial function is
an early predictor of future
cardiovascular events.
(ii) Poor health behaviours,
including smoking, sedentary
behaviour, obesity, and
excessive alcohol consumption,
have individually been
associated with endothelial
dysfunction.
(iii) These studies have
generally compared “extreme”
behaviours (e.g., marathon
runners versus sedentary
individuals).
(i) There are independent
eﬀects of current smoking
habits, obesity and alcohol
consumption on brachial artery
reactivity.
(ii) Whilst any improvement in
a single health behaviour might
have a positive inﬂuence on
endothelial function, targeting
multiple behaviours should
yield greater beneﬁts.
outcome. A total of 904 consecutive patients referred for
single-photon emission computed tomography (SPECT)
exercise stress tests between July 2005 and December 2006 in
the Nuclear Medicine Service of the Montreal Heart Institute
were recruited. To be eligible for the MOSMI study, patients
had to be undergoing SPECT exercise stress testing, be over
18 years old, and speak either English or French. Patients
were excluded if they had experienced a cardiac event (e.g.,
myocardial infarction) in the last 4 weeks, if they had a
more prominent medical condition than CVD (e.g., cancer,
chronic obstructive pulmonary disease), or were pregnant
or nursing. A subsample of 328 patients from the MOSMI
study underwent EF testing. The selection of this group from
the main cohort was done based on the random allocation
to available testing time slots. There were no diﬀerences in
age, sex, or CVD status between this subsample and those
patients recruited for the MOSMI study but who were not
included in ﬁnal analysis. The MOSMI study was approved
by the Human Ethics Committee of the Montreal Heart
Institute and written informed consent was obtained from
all participants.
2.2. Procedure. Patients presenting to the Nuclear Medicine
Service of the Montreal Heart Institute on the day of their
exercise stress test were approached to participate in the
MOSMI study. Once consent was obtained, demographic
and medical information, including health behaviours, was
collected using a self-report questionnaire and waist circum-
ference was measured. Patients then underwent standard
treadmill exercise stress testing (Bruce protocol) followed
by SPECT imaging. As per the SPECT protocol, all patients
returned the following day to complete their rest scan. Prior
to the rest scan patients underwent the forearm hyperaemic
reactivity (FHR) test to measure brachial artery reactivity
in response to hyperaemic challenge. All SPECT imaging
was conducted according to standard procedure [52–54]. In
general, patients were maintained on their usual medication,
the only exception being that people were asked to withhold
taking beta-blockers on the day of the exercise and rest
SPECT studies.International Journal of Hypertension 3
2.3. Brachial Artery Reactivity Assessment. The FHR tech-
nique, implemented by a trained Nuclear Medicine tech-
nician, was used to assess brachial artery activity. FHR
is considered a marker of EF [55, 56]. FHR measures
alterations in the brachial artery endothelium following a
hyperaemic challenge [57, 58]. The patient is seated with
both arms extended over the top of a standard large ﬁeld-
of-view gamma camera with a low negative high resolution
collimater (Scintronix, London, UK) facing upward, hands
prone. To create the hyperaemic challenge, a blood pressure
cuﬀ (Adult First Responders, B&A Instruments, New York,
New York) was placed on the right arm and inﬂated at
50mmHg above systolic blood pressure for 5 minutes, after
which it was released. Forty-ﬁve seconds after the cuﬀ
was deﬂated, 0.42mCi/kg of the radioactive tracer Tc-99m-
tetrofosmin (Myoview, Amersham Health, Princeton, NJ)
was injected into the patient’s arm via a small catheter
positioned in the bend of the left arm. For the next 10
minutes, dynamic image acquisitions were realized using 128
× 128 matrices at a sampling rate one frame per second.
From this, the ratio between the rate of blood ﬂow into the
right (the hyperaemic arm) and left (the control arm) arms,
therelativeuptakeratio(RUR),wascalculatedusingcustom-
made software (Sygesa, Montreal, Canada). The higher one’s
RUR, the better the endothelial tissue is at responding
to the hyperaemia, via the promotion of vasodilation.
Thus, a higher RUR indicates better EF and a lower RUR
indicates worse EF. More speciﬁcally, an RUR under 3.55
is considered to be indicative of endothelial dysfunction
[58]. This technique has a high level of reproducibility with
excellent intra- and interrater reliability [59].
2.4. Health Behaviours
2.4.1. Physical Activity. Leisure time physical activity was
derived from a slightly adapted 12-month version of the
Physical Activity Recall Interview [60]. Speciﬁcally, given the
nature of activity patterns in Montreal, separate details were
collected for winter-like and summer-like activities and then
combined. Physical activity levels were calculated as average
metabolic equivalents MET-hrs/week.
2.4.2. Smoking. Lifetime cigarette consumption was assessed
usingthestandardcalculationofpack/years(averagenumber
of packs smoked/day × number of years having smoked)
[61]. Patients were also classiﬁed as current, ex-, and never
smokers.
2.4.3. Obesity. As centrally distributed fat seems to be more
signiﬁcant in the aetiology of CVD [62], waist circumference
was used as our measure of central adiposity. Prior to the
EF test, the attending technician measured the participants’
waist circumference at the mid-point between the super-
illiac crest and the lower thoracic cavity.
2.4.4. Alcohol. Participants were asked to report their usual
daily or weekly consumption of alcoholic beverages. Using
this data, weekly units of alcohol consumed were estimated.
Table 2: Participant characteristics.
Variable M± SD or % (n) Data missing (%)
Age (yrs) 59.7 ±9.61 %
Sex (% women) 25% (83) 0%
Endothelial dysfunction
(RUR < 3.55) 44% (145) 0%
Average # drinks/week 13.4 ±12.88 %
Waist circumference (cm) 99.6 ±12.03 %
Leisure-time physical
activity (MET-hrs/week) 7.2 ±12.41 %
Lifetime smoking (pack
years) 15.7 ±19.69 %
Smoking status
Current: 11% (37)
Previous: 57% (188)
Never: 31% (102)
0%
Statin use 49% (157) 3%
Ace inhibitor use 26% (82) 3%
Cardiovascular disease 41% (133) 0%
Diabetes 16% (38) 0%
Hypercholesterolemia 62% (198) 2%
Hypertension 60% (196) 0%
2.5. Data Analysis. Our missing data analysis procedures
used missing at random (MAR) assumptions, as per Rubin’s
rules [63]. We used the PROC MI method of multiple
multivariate imputation in SAS. We independently analyzed
5 copies of the data, each with missing values imputed,
and then used PROC MIANALYZE to average estimates of
the variables to give a single mean estimate and adjusted
standarderrorsaccordingtoHarrell’sguidelines[64].Details
of the amount of missing data per variable are included in
Table 2.
To examine the contributions of physical activity, smok-
ing, obesity, and alcohol consumption to EF, a series of
GLMs on the individual variables was also conducted, ﬁrst
for the individual health behaviours alone, second with
the individual health behaviours and covariates, and third
for all four behaviours together and the covariates. Since
a nonlinear relationship was expected to exist between
alcohol consumption and EF, participants were split into
one of three groups in terms of their alcohol consumption.
Group 1 consisted of heavy drinkers (deﬁned as 22 or
more drinks per week), group 2 consisted of abstainers, and
group 3 consisted of moderate drinkers (1–21 drinks per
w e e k ) .T h eg r o u p sw e r ed e ﬁ n e da ss u c hs i n c ec o n s u m i n g
1–3 drinks per day has been associated with better EF
than abstinence [51], while 4 or more drinks have been
found to negatively impact EF acutely [50]. It was therefore
expected that heavy drinkers would have the worst EF and
moderate drinkers would have the best EF, creating a linear
relationship between group number and EF. Age, sex, CVD
status (CVD was deﬁned as having a previous myocardial
infarction, stroke, angioplasty, or coronary artery bypass
graft), ace inhibitor use, statin use, hypertension, diabetes,
and hypercholesterolemia were chosen as covariates ap r i o r i ,4 International Journal of Hypertension
as all have been shown to have strong independent eﬀects
on EF [7, 65–71]. To examine potential interactions between
the health behaviours an interaction term for each pair of
continuous health behaviours was included one at a time in
a GLM including the above-mentioned covariates.
To examine possible associations between the health
behaviours and risk of having endothelial dysfunction,
deﬁned as an RUR under 3.55, two logistic regression
analyses were conducted predicting endothelial dysfunction
from all four health behaviours and the covariates together.
For these analyses, waist circumference was split into tertiles:
<92cm, 92–108cm, and >108cm. Smoking was deﬁned by
smoking status (current/past/never). Alcohol consumption
was split by the groups described above. Finally, physical
activity was split into tertiles: 0, 0–9.7 and >9.7 MET-
hrs/week.
3. Results
The characteristics of the 328 participants are presented in
Table 2. The GLM analyses for individual health behaviours
revealed that waist circumference (β (SEM) = −.03 (.01), P<
.0001) contributed signiﬁcantly to EF. A trend for an eﬀect
of smoking on EF measured using pack-years (F = 1.78, P =
.075) was also found. However, physical activity (β (SEM)
= −.01 (.01), P = .528), smoking status (β (SEM) = −.22
(.15), P = .131), and alcohol consumption (β (SEM) = .19
(.12), P = .136) were not associated with EF as a continuous
variable.
GLMs for the individual health behaviours with age,
sex, CVD status, ace inhibitor use, statin use, hypertension,
diabetes, and hypercholesterolemia as covariates were then
conducted. These analyses revealed that waist circumference
(β (SEM) = −.04 (.01), P<. 0001) contributed signiﬁcantly
to the variability in EF, while physical activity (β (SEM) =
−.01 (.01), P = .398), alcohol consumption (β (SEM) = −.17
(.13), P = .167), and smoking measured according to pack-
years (β (SEM) = −.01 (.01), P = .203) or smoking status (β
(SEM) = −.21 (.15), P = .153) did not.
Results of a GLM with all covariates and health
behaviours included revealed that waist circumference was
a signiﬁcant independent predictor of EF considered as a
continuous variable (Table 3 and Figure 1). Neither alcohol
consumption, physical activity, nor smoking, measured
according to pack years were signiﬁcantly related to EF
(Table 3). Comparable results were found when lifetime
smoking was replaced by current smoking status.
The results of the GLMs separately examining the
interaction between each pair of health behaviours revealed
no signiﬁcant interaction eﬀects.
A logistic regression analysis, including all covariates and
health behaviours in the model revealed that in comparison
to the lowest tertile of waist circumference (<92cm), being
in the second tertile (92–108cm) was associated with a 90%
increased risk of endothelial dysfunction (OR = 1.90, 95%
CI =1.01–3.59).Beinginthethirdtertileforwaistcircumfer-
ence(>108cm),ontheotherhand,wasassociatedwithmore
than double the risk of endothelial dysfunction (OR = 2.39,
95% CI = 1.15–4.98). Alcohol consumption group was also
Table 3: Summary of multiple regression analysis for all health
behaviours predicting brachial artery reactivity, controlling for
age, sex, CVD status, ace inhibitor use, statin use, hypertension,
diabetes, and hypercholesterolemia.
Variable β SE tP
Waist circumference −0.03 0.01 −3.95 <.000
Physical activity −0.01 0.01 −1.01 .313
Lifetime smoking −0.00 0.01 −0.86 .392
Alcohol usage 0.14 0.12 −1.13 .258
3
1234
R
U
R
Quartile
3.2
3.4
3.6
3.8
4
4.2
4.4
4.6
4.8
5
Figure 1: Mean relative uptake ratio (RUR) as a function of
waist circumference split into quartiles, with standard error bars,
adjusting for covariates, smoking, physical activity, and alcohol
consumption.
a signiﬁcant predictor of endothelial dysfunction such that
being a nondrinker versus a moderate drinker was associated
with nearly double the risk of endothelial dysfunction (OR =
1.99, 95% CI = 1.08–3.70), while the risk associated with
being a heavy drinker did not diﬀer from being a moderate
drinker (OR = 1.57, 95% CI = 0.82–2.86). Being a past
smokerversusaneversmokerwasassociatedwithdoublethe
risk of endothelial dysfunction (OR = 2.00, 95% CI = 1.26–
3.75), while the risk associated with being a current smoker
did not reach signiﬁcance (OR = 2.17, 95% CI = 0.88–4.84).
Finally, the odds ratios for being in the ﬁrst (OR = 0.82, 95%
CI = 0.44–1.53) or second tertile (OR = 1.29, 95% CI = 0.70–
2.35)incomparisonwiththethirdtertileforphysicalactivity
were not signiﬁcant (Figure 2).
4. Discussion
This study is the ﬁrst attempt to assess the eﬀects of waist
circumference, physical activity, alcohol consumption, and
smoking on EF in a single sample of cardiac patients.
The GLM analyses revealed that waist circumference was
negatively associated with continuous variations in EF and
that there was a trend for a signiﬁcant negative association
between lifetime smoking and EF when they were each
included in the model alone. However, when covariates
were added to the model, this trend disappeared but the
signiﬁcant eﬀect of waist circumference on EF remained.
When all four health behaviours were included in the same
model with the covariates, only waist circumference was
signiﬁcantly associated with EF considered as a continuousInternational Journal of Hypertension 5
Current versus never
>108 versus <92 cm
Waist circ.: 92–108 versus <92 cm
Heavy versus moderate
Alcohol:  None versus moderate
Smoking: Past versus never
0–9.7 versus >9.7 MET-hrs/week
Phys. act.: 0 versus >9.7 MET-hrs/week
Odds ratio (95% CI)
0.3 1.3 2.3 3.3 4.3
Figure 2:Forestplotofodds-ratiosand95%conﬁdenceintervalsfortheeﬀectofeachhealthbehaviouronendothelialdysfunctionadjusting
for covariates and the other health behaviours.
variable. Additional logistic regression analyses, including all
four health behaviours and covariates together, revealed that
increased waist circumference also increased risk for clin-
ical endothelial dysfunction. Surprisingly, abstinence from
alcohol and past smoking predicted endothelial dysfunction,
while heavy alcohol consumption and current smoking did
not.
The current ﬁndings suggest that central adiposity is
negatively associated with EF. Consistent with the current
ﬁndings, several studies have found measures of central
adiposity such as waist circumference and waist-hip ratio,
to be predictors of cardiovascular outcomes in patients both
with [72] and without [73–77] known CVD. Although the
exact mechanism behind this obesity-induced increase in
endothelial dysfunction is unclear, two candidate processes
have been proposed: (1) via alternations in adipokine levels;
and (2) via increases in free fatty acid levels. In brief, it
would appear that increasing levels of obesity are associated
with increases in adipokines that negatively inﬂuence the
endothelium [78], and decreases in adipokines that exert
positiveeﬀectsontheendothelium[79].Forexample,leptin,
which is increased in obese patients, has been shown to
increase the release of reactive oxygen species in human
endothelial cells [78], thus diminishing the bioavailability of
nitric oxide (NO), an important vasodilator and inhibitor
of inﬂammation and platelet aggregation. Alternatively,
adiponectin, which is downregulated in obese individuals
[79], stimulates nitric oxide production, and promotes
vasodilation [80]. Recent studies have also found increased
levels of endothelial dysfunction when free fatty acids, which
are abundant in patients with abdominal obesity [81], were
administeredexogenously[82,83].Thisalterationisthought
tooccurbyfreefattyacidsdecreasingendothelialnitricoxide
synthase (eNOS) activity [82].
Theﬁndingsregardingcigarettesmoking andalcoholuse
are somewhat more complex. That is, GLM analyses indicate
that these variables were not associated with continuous
ﬂuctuations of EF. However, the logistic regression analyses
reveal that past (but not current) smoking and abstinence
from alcohol (but not heavy consumption) both increased
the risk of endothelial dysfunction. The fact that the odds
ratios for current smoking did not reach signiﬁcance may
be partially due to small sample sizes since relatively few
participants were current smokers. The ﬁnding that past
smoking was associated with an increased risk of endothe-
lial dysfunction suggests that smoking-induced endothelial
damage is long lasting. This is consistent with previous
research ﬁnding that the somewhat improved ﬂow-mediated
dilation of former smokers was not statistically greater
than current smokers [6]. Smoking is thought to damage
endothelial cells directly [84] and to increase oxidative stress,
thereby decreasing nitric oxide availability [85]. Smoking
also appears to reduce the immune system’s ability to
repair this endothelial damage by decreasing the number of
circulating endothelial progenitor cells, which are mobilised
in response to vascular injury [86]. Following smoking
cessation, the number of circulating endothelial progenitor
cells has been found to increase rapidly [87], suggesting that
the EF of ex-smokers should begin improving soon after
quitting. However, it is unknown to what extent the length of
time of smoking or the length of time since quitting impacts
current EF. It may therefore be the case that the ex-smokers
in the current study had either smoked too long or had not
been smoke-free long enough to exhibit fully recovered EF.
Our ﬁnding that heavy alcohol consumption is not
associated with greater risk of endothelial dysfunction
is inconsistent with previous research ﬁnding that heavy
consumption has been found to induce endothelial cell
apoptosis by increasing oxidative stress [88] and impairing
nitric oxide production [89]. This ﬁnding may therefore
be related to sample size, considering the relatively small
numberofheavydrinkersinthecurrentstudy.However,that
moderate alcohol consumption is associated with better EF
than abstinence is consistent with previous ﬁndings [51]. It
is believed that moderate alcohol consumption may improve
EFbyincreasingNOlevels[90]anddecreasinghomocysteine
levels, which is an amino acid causing oxidative stress [91].
That physical activity was not found to be associated
with EF is inconsistent with studies comparing sedentary
individualswithathletes[9–11]butisconsistentwiththeone
study that has examined the relationship between moderate
physical activity and EF in adults [30]. This ﬁnding suggests
that physical activity may contribute little to EF among
moderately active individuals at high risk for cardiovascular
diseasewholikelyengageinseveralpoorhealthbehavioursat
once. Considering the average participant in this study does
not meet the minimum requirements for physical activity
set by the American College of Sports Medicine and the6 International Journal of Hypertension
American Heart Association [92], which is between 7.5 and
12.5MET-hrs/week, greater levels of physical activity may be
needed to see its eﬀect on EF.
Of course, the results of the current study must be
considered in light of some limitations. As with all cross-
sectional studies, it is impossible to draw conclusions
about the cause and eﬀect relationship between the health
behaviours assessed and EF. The current study also used
retrospective self-report measures for physical activity, alco-
hol consumption, and smoking, which may be susceptible
to recall bias. Drink type was also not taken into account
for alcohol consumption, which is problematic given that
wine has been found to have a unique beneﬁcial eﬀect on
EF [47, 93]. Our failure to record patients’ use of nicotine
replacement therapy, known to aﬀect EF [94], is also a
limitation.
While the current study has its limitations, the fact
that it examined the relationship between EF and smoking,
obesity, physical activity, and alcohol consumption in the
same statistical model is an important and unique strength.
While other studies that have examined the eﬀect of only one
health behaviour on EF risk overestimating the portion of
variance in EF explained by the behaviour, the present study
should more accurately estimate the independent eﬀect of
each health behaviour on EF. This is particularly true since
poor health behaviours tend to aggregate. It is also a strength
that this study examined the eﬀect of health behaviours on
EF in a sample of patients at risk for cardiovascular disease
since poor health behaviours would be expected to have the
most important and imminent impact in this population.
Other strengths of this study include its large sample size,
the inclusion of several important covariates, and the quality
of the health behaviour measures used. Finally, despite the
relative novelty of the FHR technique, it has been shown to
be highly reliable [59] and reproducible [58, 95].
In conclusion, the results of this study indicate that
central adiposity and smoking are independently associated
with worsening EF, while moderate alcohol consumption
appearstohaveanindependentpositiveeﬀectonEF.Physical
activity, on the other hand, does not seem to be associated
with EF when controlling for other health behaviours and
relevant covariates. These ﬁndings may imply that within
a population exhibiting numerous risk factors for cardio-
vascular disease, weight reduction, smoking cessation, and
moderate alcohol consumption should be emphasized and
prioritized over increasing physical activity as interventions
to improve patients’ cardiovascular proﬁles. This prioriti-
zation may be particularly helpful given the diﬃculty with
which individuals change just one health behaviour. Further
work is needed to conﬁrm the mechanisms by which central
adiposity, smoking and alcohol consumption inﬂuence EF.
Furtherresearchisalsoneededtoexaminetheeﬀectofhealth
behaviours on EF over a longer period of time to examine
how EF changes as a function of health behaviours over
time. Future research should also aim to assess the extent
to which the relationship between health behaviours and
cardiovascular disease is explained by the impact of health
behaviours on EF.
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